You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Encorafenib with cetuximab and FOLFOX for untreated BRAF V600E mutation-positive metastatic colorectal cancer [ID6734]

  • Awaiting development
  • Reference number: GID-TA11961
  • Expected publication date: TBC
  • Project information
  • Project documents

30684-Encorafenib-Cetuximab-Chemotherapy-for-Colorectal-Cancer-V1.0-DEC2025-NON-CONF.pdf

Back to top